Follow The Filings

PCVX Vaxcyte Inc.

Health Care, filed as VAXCYTE INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q3

  • 1 Owner
  • Max 0.6%
  • $77M
  • 1 reduce

In 2026 Q3 Lee Ainslie trimmed Vaxcyte.

Who owns this now

Largest portfolio weights among holders, up to 0.6% (Lee Ainslie, Maverick Capital). Not free-float ownership.

  1. Lee Ainslie Reduce 0.60%

Who owns PCVX

Sorted by value, long equity only, as of 2026 Q3.

History
Lee Ainslie, Maverick Capital 0.60%, was 0.82% Reduce −15.7% 1,360,031 $77M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by PCVX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PCVX insider trades
  • None no insider bought on the open market
  • $1M sold by 2 insiders outside a trading plan
  • $12.9M sold by 5 insiders under 10b5-1 plans
  1. Harpreet S. Dhaliwal Chief Technical Ops Officer
    Planned sale
    $1.2M 17,000 shares at $67.83 20% of stake
    Traded Nov 11 Filed Nov 13
  2. Elvia Cowan SVP, Finance & CAO
    Planned sale
    $183K 3,000 shares at $60.92 9.7% of stake
    Traded Nov 2 Filed Nov 4
  3. Jim Wassil COO
    Planned sale
    $137K 2,250 shares at $60.90 1.5% of stake
    Traded Nov 2 Filed Nov 4
  4. Elvia Cowan SVP, Finance & CAO
    Planned sale
    $1.6M 19,000 shares at $86.74 41% of stake
    Traded Oct 5 Filed Oct 7
  5. Jim Wassil COO
    Planned sale
    $1.6M 18,000 shares at $86.74 11% of stake
    Traded Oct 5 Filed Oct 7
  6. Jim Wassil COO
    Planned sale
    $128K 2,250 shares at $56.67 1.5% of stake
    Traded Oct 1 Filed Oct 2
  7. Jim Wassil COO
    Planned sale
    $164K 2,715 shares at $60.35 1.8% of stake
    Traded Sep 4–9 Filed Sep 9
  8. Jim Wassil COO
    Planned sale
    $212K 3,477 shares at $61.07 2.2% of stake
    Traded Sep 1 Filed Sep 2
  9. Harpreet S. Dhaliwal Chief Technical Ops Officer
    Planned sale
    $935K 17,000 shares at $55.00 18% of stake
    Traded Aug 5 Filed Aug 5
  10. Jim Wassil COO
    Planned sale
    $121K 2,250 shares at $53.86 1.4% of stake
    Traded Aug 3 Filed Aug 5
  11. Andrew Guggenhime CFO
    Planned sale
    $539K 10,000 shares at $53.89 8.7% of stake
    Traded Aug 3 Filed Aug 5
  12. Grant Pickering CEO
    Planned sale
    $1M 18,198 shares at $55.63
    Traded Jul 27 Filed Jul 28
  13. Jim Wassil COO
    Planned sale
    $127K 2,250 shares at $56.33 1.4% of stake
    Traded Jul 1 Filed Jul 6
  14. Andrew Guggenhime CFO
    Planned sale
    $573K 10,000 shares at $57.28 8.7% of stake
    Traded Jul 6 Filed Jul 6
  15. Grant Pickering CEO
    Planned sale
    $1.3M 24,237 shares at $55.22
    Traded Jun 26 Filed Jun 26

Also filed in the last 12 months, not counted as buying or selling: 31 share withholdings for taxes, 18 option exercises, 16 stock grants, and 4 gifts.

Congress

2 members of Congress traded PCVX in the last three years: 6 buys and 1 sale. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jul 16 filed Sep 4
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K May 13 filed Jun 8
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K May 12 filed Jun 8
  4. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Apr 28, 2025 filed May 6, 2025
  5. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Apr 15, 2025 filed May 6, 2025
  6. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Apr 14, 2025 filed May 6, 2025

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 1.01,2.03,8.01,9.01
424B5
424B5
424B5
424B5
8-K 7.01,8.01,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.02

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$402.27M -$463.93M -$766.63M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.1B $1.79B $1.63B
Total non-current assets $0.312B $1.72B $1.38B
Total assets $1.41B $3.51B $3B
Total current liabilities $145.34M $140.18M $205.75M
Total non-current liabilities * $22.11M $65.32M $111.46M
Total equity $1.24B $3.31B $2.69B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$296.79M -$452.63M -$655.58M
Cash from investing -$0.773B -$2.01B $0.437B
Cash from financing $0.64B $2.45B $0.002B
Net change in cash -$436.97M -$9.36M -$213.77M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf